High Expression of MDR1 is Correlated with Poor Prognosis for Common Malignancies
Bo Gao1,2, Fengmei Yang3, Wei Chen2, Xiaojia Song4, Xiaobo Liu5 and Dongmin Li1*
The relative expression levels of MDR1 in all tissues.
Recurrence time and survival time in different groups. PEOC: primary epithelial ovarian cancer; NSCLC: non-small cell lung cancer; MDR1: multidrug resistance 1; MDR1+: MDR1 positive group; MDR1-: MDR1 negative group.
The ROC analysis of MDR1 expression and tumor markers in the prognosis of common malignant tumor.
Survival curves of MDR1 mRNA-positive and negative patients. A: non-small cell lung cancer; B: colorectal cancer; C: primary epithelial ovarian cancer; D: gastric cancer; E:breast cancer.